Skip to Main content Skip to Navigation
Journal articles

The Triggering Receptor Expressed on Myeloid cells-1: A new player during acute myocardial infarction

Abstract : Following myocardial ischemia, an intense activation of the immune system occurs that leads to inflammatory cytokines and chemokines production and to the recruitment of neutrophils and mononuclear cells in the infarcted area. Although pro-inflammatory signals initiate the cellular events necessary for scar formation, excessive and prolonged inflammation promotes deleterious cardiac remodeling and dysfunction. The triggering receptor expressed on myeloid cells-1 (TREM-1) is a highly conserved immune-receptor expressed by neutrophils and monocytes that acts as an amplifier of the innate immune response. Blockade of TREM-1 activation protects from hyper-responsiveness and death during severe infections. Here we review the role of TREM-1 in orchestrating the inflammatory response that follows MI. TREM-1 deletion (Trem-1-/-) or modulation by the use of a short inhibitory peptide (LR12) dampens myocardial inflammation, limits leukocyte recruitment, and improves heart function and survival in mice or pigs. Moreover, the soluble form of TREM-1 (sTREM-1) is found in the plasma of patients suffering from an acute MI and its concentration is an independent predictor of death. This suggests that TREM-1 may constitute a new therapeutic target during acute MI.
Complete list of metadata
Contributor : DCAC UL Connect in order to contact the contributor
Submitted on : Wednesday, April 4, 2018 - 5:24:50 PM
Last modification on : Tuesday, October 13, 2020 - 10:45:50 AM




Jérémie Lemarié, Amir Boufenzer, Marc Derive, Sébastien Gibot. The Triggering Receptor Expressed on Myeloid cells-1: A new player during acute myocardial infarction. Pharmacological Research, Elsevier, 2015, 100, pp.261 - 265. ⟨10.1016/j.phrs.2015.07.027⟩. ⟨hal-01758752⟩



Record views